Trial Profile
Real World Study of Bevacizumab in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Cisplatin; Gemcitabine; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 27 Oct 2016 New trial record